Abstract
ObjectivesTo evaluate the recapture of response with open-label (OL) ixekizumab (IXE) retreatment at week 104 in patients with axial spondyloarthritis who flared after withdrawal of IXE therapy.MethodsCOAST-Y (NCT03129100) is a...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have